EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced the addition of a new independent board member, Shawn McCormick, a highly experienced medical device executive. McCormick’s appointment became effective on December 18, 2015. As reconstituted, the board now consists of seven members, six of whom are independent.
